Multicomponent Pseudomonas aeruginosa Vaccines Eliciting Th17 Cells and Functional Antibody Responses Confer Enhanced Protection against Experimental Acute Pneumonia in Mice
Abstract
The Gram-negative pathogen Pseudomonas aeruginosa is a common cause of pneumonia in hospitalized patients. Its increasing antibiotic resistance and widespread occurrence present a pressing need for vaccines.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Oct 20, 2022
- Source ID
- 10.1128/iai.00203-22
Entities
People
- Antonio DiGiandomenico
- Christina Merakou
- David E. Tabor
- David Zurakowski
- Gregory Priebe
- Marco DiBlasi
- Margaret Kehl
- Matthew M Schaefers
- Mohammad Omar Faruk Shaikh
- Sarah Bonney
- Tiffany Liao
Organizations
- AstraZeneca
- Boston Children's Hospital
- Harvard Medical School
- United States Department of Defense